View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Polymyositis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 09, 2022
2 min read
Save

Patients with pediatric dermatomyositis need guidance on disease ‘rollercoaster’

Patients with pediatric dermatomyositis need guidance on disease ‘rollercoaster’

Guiding patients with juvenile dermatomyositis from pediatric to adult care is essential to minimize comorbidities and complications, according to data presented at EULAR 2022 Congress.

SPONSORED CONTENT
June 06, 2022
2 min read
Save

Specialized physiotherapy may improve sexual health in women with systemic sclerosis

Specialized physiotherapy may improve sexual health in women with systemic sclerosis

Specialized physical therapy may prevent deterioration and improve sexual function in female patients with systemic sclerosis and idiopathic inflammatory myopathies, according to data presented at the EULAR 2022 Congress.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
May 24, 2022
1 min read
Save

Myositis Awareness Month sheds light on patient voices, disease costs

Myositis Awareness Month sheds light on patient voices, disease costs

Myositis Awareness Month is focused on raising awareness and amplifying voices for patients with diseases falling under the myositis umbrella.

SPONSORED CONTENT
May 15, 2022
3 min read
Save

Hydroxychloroquine no longer best treatment for systemic dermatomyositis

Hydroxychloroquine no longer best treatment for systemic dermatomyositis

DESTIN, Fla. — Hydroxychloroquine may no longer be the optimal treatment option for systemic dermatomyositis, according to data presented at the Congress of Clinical Rheumatology East.

SPONSORED CONTENT
March 23, 2022
1 min read
Save

‘Stronger together’: Rheumatology groups build community for Autoimmune Awareness Month

‘Stronger together’: Rheumatology groups build community for Autoimmune Awareness Month

March is Autoimmune Awareness Month, and rheumatology organizations have been using their reach and influence on social media sites to spread the word and help patients with autoimmune diseases find community.

SPONSORED CONTENT
February 24, 2022
2 min read
Save

Nintedanib slows FVC decline in autoimmune-related interstitial lung disease

Nintedanib slows FVC decline in autoimmune-related interstitial lung disease

Nintedanib slows the rate of forced vital capacity decline in patients with fibrosing autoimmune disease-related interstitial lung disease, with adverse events manageable for most, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
February 21, 2022
2 min read
Save

High anti-CCP, pain in hands, feet linked to increased risk for inflammatory arthritis

High anti-CCP, pain in hands, feet linked to increased risk for inflammatory arthritis

High anti-cyclic citrullinated peptide levels and pain in the hands or feet indicate an increased risk for progression to inflammatory arthritis, especially rheumatoid arthritis, according to data published in Arthritis Research & Therapy.

SPONSORED CONTENT
January 25, 2022
3 min read
Save

'Waste of energy': One-third of connective tissue disease RCTs never completed, published

'Waste of energy': One-third of connective tissue disease RCTs never completed, published

One out of three registered randomized controlled trials on connective tissue diseases are never completed or published, representing a “waste of energy or resources” that may skew meta-analyses, according to researchers.

SPONSORED CONTENT
January 20, 2022
52 min listen
Save

Leadership, Research and Patient Care with Kristin Highland, MS, MD

Leadership, Research and Patient Care with Kristin Highland, MS, MD

Kristin B. Highland, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.

SPONSORED CONTENT
January 12, 2022
2 min read
Save

Flares, breakthroughs rare after COVID-19 vaccination in inflammatory rheumatic disease

Flares, breakthroughs rare after COVID-19 vaccination in inflammatory rheumatic disease

Just 0.7% of fully vaccinated patients with inflammatory rheumatic and musculoskeletal disease experience a breakthrough COVID-19 infection, while only 4.4% demonstrate disease flare reactions, according to data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails